Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
复制标题
DOI:
10.3174/ajnr.a4631
复制
发表时间:
2016-04
期刊:
影响因子:
--
通讯作者:
Rubin DL
中科院分区:
文献类型:
--
作者:
Liu TT;Achrol AS;Mitchell LA;Du WA;Loya JJ;Rodriguez SA;Feroze A;Westbroek EM;Yeom KW;Stuart JM;Chang SD;Harsh GR 4th;Rubin DL
Tumor location has been shown to be a significant prognostic factor in patients with glioblastoma (GBM). The purpose of this study is to characterize GBM lesions by identifying MRI voxel-based tumor location features that are associated with tumor molecular profiles, patient characteristics and clinical outcomes. Preoperative T1 anatomic MR images of 384 GBM patients were obtained from two independent cohorts (N=253 from our local (name withheld to preserve anonymity) Medical Center for training and N=131 from the Cancer Genome Atlas (TCGA) for validation). An automated computational image analysis pipeline was developed to determine the anatomic locations of tumor in each patient. Voxel-based differences in tumor location between good (overall survival (OS) > 17 months) and poor (OS < 11 months) survival groups identified in the training cohort were used to classify patients in the TCGA cohort into two brain location groups, for which clinical features, mRNA expression, and copy number changes were compared to elucidate the biological basis of tumors located in different brain regions. Tumors in the right occipito-temporal periventricular white matter were significantly associated with poor survival in both training and test cohorts (both log-rank P < 0.05) and had larger tumor volume compared to tumors in other locations. Tumors in the right peri-atrial location were associated with hypoxia pathway enrichment and PDGFRA amplification, making them potential targets for subgroup-specific therapies. Voxel-based location in GBM is associated with patient outcome and may have a potential role for guiding personalized treatment.